It's a large, new study that raises doubts about the value of mammograms in preventing breast cancer deaths, but a lot of the publicity and debate about it seems to have missed an important point.
Hopes for a screening test that could detect ovarian cancer early - something that has eluded the fight against this lethal disease - were boosted this week with results from an important new study.
It's a drug used to treat an enlarged prostate, as well as male-pattern baldness, and 10 years ago a study indicated it could reduce a man's risk of developing prostate cancer by 30 percent.
For men who undergo a biopsy for a prostate tumor, the big question has been whether to wait and see if the cancer grows slowly, or to treat it immediately with a regimen that could cause incontinence or impotence.
"Screening saves lives" has long been the mantra of breast cancer groups and doctors. But a longtime critic of Americans' zeal for screening says new research shows that up to a third of cancers detected through routine mammograms may not be life-threatening.
Search AARP Blogs